These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 29914961

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
    Mendes RE, Moet GJ, Janechek MJ, Jones RN.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2704-6. PubMed ID: 20385851
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
    Crandon JL, Kuti JL, Nicolau DP.
    Antimicrob Agents Chemother; 2010 Dec; 54(12):5115-9. PubMed ID: 20837760
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.
    Kidd JM, Sakon CM, Oleksiuk LM, Cies JJ, Pettit RS, Nicolau DP, Kuti JL.
    Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31685468
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of ceftaroline: A novel antibiotic against methicillin-resistant Staphylococcus aureus.
    Gaikwad V, Gohel T, Panickar S, Chincholkar V, Mangalkar S.
    Indian J Pathol Microbiol; 2016 Dec 20; 59(4):496-498. PubMed ID: 27721280
    [Abstract] [Full Text] [Related]

  • 17. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression.
    Rose WE, Fallon M, Moran JJ, Vanderloo JP.
    Antimicrob Agents Chemother; 2012 Aug 20; 56(8):4422-7. PubMed ID: 22687502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative efficacy of telavancin and daptomycin in experimental endocarditis due to multi-clonotype MRSA strains.
    Xiong YQ, Abdelhady W, Tang C', Bayer AS.
    J Antimicrob Chemother; 2016 Oct 20; 71(10):2890-4. PubMed ID: 27353467
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial Activity of Telavancin Tested In Vitro Against a Global Collection of Gram-Positive Pathogens, Including Multidrug-Resistant Isolates (2015-2017).
    Duncan LR, Sader HS, Huband MD, Flamm RK, Mendes RE.
    Microb Drug Resist; 2020 Aug 20; 26(8):934-943. PubMed ID: 32049591
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.